PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
IS3S.DE vs. NOVO-B.CO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

IS3S.DE vs. NOVO-B.CO

Last updated Jun 13, 2026

IS3S.DE (iShares Edge MSCI World Value Factor UCITS ETF) is Global Equities fund tracking the MSCI World Enhanced Value, while NOVO-B.CO (Novo Nordisk A/S) is a stock. Over the past 10 years, IS3S.DE returned 12.98%/yr vs 17.26%/yr for NOVO-B.CO. At a 0.29 correlation, their price movements are largely independent.

Performance

IS3S.DE vs. NOVO-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares Edge MSCI World Value Factor UCITS ETF (IS3S.DE) and Novo Nordisk A/S (NOVO-B.CO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

IS3S.DE is traded in EUR, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, IS3S.DE achieves a 34.68% return, which is significantly higher than NOVO-B.CO's -8.77% return. Over the past 10 years, IS3S.DE has underperformed NOVO-B.CO with an annualized return of 12.98%, while NOVO-B.CO has yielded a comparatively higher 17.26% annualized return.

IS3S.DE

1D
2.88%
1M
5.58%
YTD
34.68%
6M
37.30%
1Y
63.13%
3Y*
25.47%
5Y*
17.18%
10Y*
12.98%

NOVO-B.CO

1D
1.61%
1M
-4.08%
YTD
-8.77%
6M
-7.60%
1Y
-41.92%
3Y*
4.37%
5Y*
20.51%
10Y*
17.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IS3S.DE vs. NOVO-B.CO - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
IS3S.DE
iShares Edge MSCI World Value Factor UCITS ETF		34.68%25.13%11.36%15.62%-4.81%30.35%-12.53%22.01%-10.32%7.66%
NOVO-B.CO
Novo Nordisk A/S		-8.77%-46.44%-9.91%205.51%31.09%79.61%15.78%35.77%-6.27%39.30%

Correlation

The correlation between IS3S.DE and NOVO-B.CO is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Oct 6, 2014

0.29

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

iShares Edge MSCI World Value Factor UCITS ETF

Novo Nordisk A/S

Often compared with IS3S.DE:
IS3S.DE vs. XDEM.DEIS3S.DE vs. AVLVIS3S.DE vs. QDVX.DEIS3S.DE vs. IUSQ.DEIS3S.DE vs. SPWOIS3S.DE vs. GACA.DEIS3S.DE vs. AVUV
Often compared with NOVO-B.CO:
NOVO-B.CO vs. SPYNOVO-B.CO vs. LLYNOVO-B.CO vs. QQQNOVO-B.CO vs. NOV.DENOVO-B.CO vs. SAABYNOVO-B.CO vs. LLY.DENOVO-B.CO vs. MONC.MI

Return for Risk

IS3S.DE vs. NOVO-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
IS3S.DE
IS3S.DE Risk / Return Rank: 9797
Overall Rank
IS3S.DE Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
IS3S.DE Sortino Ratio Rank: 9797
Sortino Ratio Rank
IS3S.DE Omega Ratio Rank: 9696
Omega Ratio Rank
IS3S.DE Calmar Ratio Rank: 9797
Calmar Ratio Rank
IS3S.DE Martin Ratio Rank: 9797
Martin Ratio Rank
NOVO-B.CO
NOVO-B.CO Risk / Return Rank: 1313
Overall Rank
NOVO-B.CO Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
NOVO-B.CO Sortino Ratio Rank: 1414
Sortino Ratio Rank
NOVO-B.CO Omega Ratio Rank: 1212
Omega Ratio Rank
NOVO-B.CO Calmar Ratio Rank: 1313
Calmar Ratio Rank
NOVO-B.CO Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IS3S.DE vs. NOVO-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Edge MSCI World Value Factor UCITS ETF (IS3S.DE) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

IS3S.DENOVO-B.CODifference
Sharpe ratioReturn per unit of total volatility
4.29
-0.79

+5.08

Sortino ratioReturn per unit of downside risk
5.83
-0.92

+6.74

Omega ratioGain probability vs. loss probability

1.77

0.87

+0.90

Calmar ratioReturn relative to maximum drawdown

10.20

-0.78

+10.98

Martin ratioReturn relative to average drawdown

37.08

-1.15

+38.24

IS3S.DE vs. NOVO-B.CO - Sharpe Ratio Comparison

The current IS3S.DE Sharpe Ratio is 4.29, which is higher than the NOVO-B.CO Sharpe Ratio of -0.79. The chart below compares the historical Sharpe Ratios of IS3S.DE and NOVO-B.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

IS3S.DE vs. NOVO-B.CO - Drawdown Comparison

The maximum IS3S.DE drawdown since its inception was -35.19%, smaller than the maximum NOVO-B.CO drawdown of -76.81%. Use the drawdown chart below to compare losses from any high point for IS3S.DE and NOVO-B.CO.

Loading charts...

Drawdown Indicators

IS3S.DENOVO-B.CODifference

Max Drawdown

Largest peak-to-trough decline

-35.19%

-76.81%

+41.62%

Max Drawdown (1Y)

Largest decline over 1 year

-6.09%

-54.72%

+48.63%

Max Drawdown (3Y)

Largest decline over 3 years

-17.78%

-76.81%

+59.03%

Max Drawdown (5Y)

Largest decline over 5 years

-17.78%

-76.81%

+59.03%

Max Drawdown (10Y)

Largest decline over 10 years

-35.19%

-76.81%

+41.62%

Current Drawdown

Current decline from peak

-1.26%

-70.26%

+69.00%

Average Drawdown

Average peak-to-trough decline

-6.96%

-11.90%

+4.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.68%

37.20%

-35.52%

Volatility

IS3S.DE vs. NOVO-B.CO - Volatility Comparison

The current volatility for iShares Edge MSCI World Value Factor UCITS ETF (IS3S.DE) is 5.87%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 11.47%. This indicates that IS3S.DE experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

IS3S.DENOVO-B.CODifference

Volatility (1M)

Calculated over the trailing 1-month period

5.87%

11.47%

-5.60%

Volatility (6M)

Calculated over the trailing 6-month period

12.05%

39.57%

-27.52%

Volatility (1Y)

Calculated over the trailing 1-year period

14.51%

54.44%

-39.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

13.97%

58.61%

-44.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.66%

45.19%

-28.53%

Dividends

IS3S.DE vs. NOVO-B.CO - Dividend Comparison

IS3S.DE has not paid dividends to shareholders, while NOVO-B.CO's dividend yield for the trailing twelve months is around 4.07%.

PositionTTM20252024202320222021202020192018201720162015
IS3S.DE
iShares Edge MSCI World Value Factor UCITS ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NOVO-B.CO
Novo Nordisk A/S		4.07%3.58%1.59%1.01%2.38%2.54%4.03%4.22%5.27%4.54%7.38%2.50%

Frequently Asked Questions

IS3S.DE and NOVO-B.CO have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for IS3S.DE and NOVO-B.CO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer